Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
VERTEX PHARMACEUTICALS INC / MA (VRTX)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 2.7 | 2.9 | 3.3 | 3.8 | 3.5 | 2.9 | 3.1 | 2.7 |
| Asset turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.8 | 0.6 | 0.4 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | 79.7% | 76.7% | 92.3% | 39.1% | 125.3% | -193.0% | 1.1% | -37.3% |
| ROIC (including intangibles) | 66.3% | 49.3% | 59.6% | 25.2% | 88.5% | -194.6% | 1.1% | -36.9% |
| ROE | 23.3% | 23.6% | 28.7% | 16.7% | 52.1% | -112.3% | 1.0% | -44.8% |
| ROA | 18.9% | 17.7% | 21.2% | 12.2% | 37.0% | -64.7% | 0.5% | -19.6% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 58.9 | 54.8 | 52.1 | 55.5 | 49.1 | 41.3 | 43.0 | 61.5 |
| Days payables outstanding | | 78.7 | 76.9 | 58.4 | 98.9 | 98.2 | 106.6 | 233.5 |
| Days inventory outstanding | 155.6 | 142.5 | 139.2 | 111.6 | 110.8 | 148.4 | 134.6 | 178.2 |
| Cash conversion cycle | 214.6 | 118.6 | 114.4 | 108.8 | 61.0 | 91.5 | 71.0 | 6.2 |
|